RE: Clinical trials update22 Mar 2022 14:56
AB - not sure I’d go along with either something to hide, or a lack of respect for shareholders. Yes, I’d agree newsflow isn’t much more than a dribble right now but that can and I expect will change given patience. The response I expect to that, will be along the lines of “we’ve been hearing that for 10 years” but I don’t believe that retort aligns to the post Redmile investment period and comparing what was happening 3, 5 or 10 years ago isn’t the way to think.
Interims were just a few weeks back and within the Outlook section - “ The Directors believe that the Company is well-funded and its diverse pipeline, based upon its proprietary platforms, is on track to deliver multiple value inflection points over the next 18 months.”
So an investor in Scancell either believes in that timeline and acknowledges that, or they don’t.
All IMO of course!